Skip to main content
. 2020 Sep 22;5(40):25733–25746. doi: 10.1021/acsomega.0c03004

Figure 2.

Figure 2

Visual predictive check of the final pharmacokinetic model showing the observed lung and plasma concentrations of SEN023, SEN066, and SEN089 with the observed median and the 2.5th and 97.5th percentiles following intratracheal administration of the suspension formulation and their corresponding 95% confidence intervals computed from the simulated data (shaded).